nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—NR3C2—dilated cardiomyopathy	0.494	1	CbGaD
Nimodipine—NR3C2—Spironolactone—dilated cardiomyopathy	0.33	1	CbGbCtD
Nimodipine—CACNA1D—sinoatrial node—dilated cardiomyopathy	0.0157	0.407	CbGeAlD
Nimodipine—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00266	0.106	CcSEcCtD
Nimodipine—Felodipine—TNNC1—dilated cardiomyopathy	0.00191	0.68	CrCbGaD
Nimodipine—AHR—cardiac ventricle—dilated cardiomyopathy	0.00176	0.0456	CbGeAlD
Nimodipine—CACNA1S—heart—dilated cardiomyopathy	0.00174	0.0452	CbGeAlD
Nimodipine—AHR—myocardium—dilated cardiomyopathy	0.00165	0.0429	CbGeAlD
Nimodipine—CACNB1—heart—dilated cardiomyopathy	0.00163	0.0421	CbGeAlD
Nimodipine—CACNB2—cardiac ventricle—dilated cardiomyopathy	0.0016	0.0414	CbGeAlD
Nimodipine—CACNB3—heart—dilated cardiomyopathy	0.00156	0.0404	CbGeAlD
Nimodipine—CACNB2—myocardium—dilated cardiomyopathy	0.0015	0.0389	CbGeAlD
Nimodipine—CACNA1C—cardiac ventricle—dilated cardiomyopathy	0.00129	0.0334	CbGeAlD
Nimodipine—NR3C2—cardiac ventricle—dilated cardiomyopathy	0.00117	0.0304	CbGeAlD
Nimodipine—AHR—heart—dilated cardiomyopathy	0.00115	0.0299	CbGeAlD
Nimodipine—NR3C2—myocardium—dilated cardiomyopathy	0.0011	0.0286	CbGeAlD
Nimodipine—CACNB2—heart—dilated cardiomyopathy	0.00105	0.0272	CbGeAlD
Nimodipine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00102	0.0406	CcSEcCtD
Nimodipine—AHR—cardiac atrium—dilated cardiomyopathy	0.000988	0.0256	CbGeAlD
Nimodipine—Felodipine—NR3C2—dilated cardiomyopathy	0.000899	0.32	CrCbGaD
Nimodipine—CACNB2—cardiac atrium—dilated cardiomyopathy	0.000896	0.0232	CbGeAlD
Nimodipine—CACNA1C—heart—dilated cardiomyopathy	0.000845	0.0219	CbGeAlD
Nimodipine—CACNA1D—cardiac atrium—dilated cardiomyopathy	0.000783	0.0203	CbGeAlD
Nimodipine—NR3C2—heart—dilated cardiomyopathy	0.000769	0.0199	CbGeAlD
Nimodipine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000762	0.0302	CcSEcCtD
Nimodipine—CACNA1C—cardiac atrium—dilated cardiomyopathy	0.000723	0.0187	CbGeAlD
Nimodipine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000658	0.0261	CcSEcCtD
Nimodipine—NR3C2—cardiac atrium—dilated cardiomyopathy	0.000658	0.0171	CbGeAlD
Nimodipine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000621	0.0246	CcSEcCtD
Nimodipine—Wheezing—Lisinopril—dilated cardiomyopathy	0.000621	0.0246	CcSEcCtD
Nimodipine—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000607	0.0241	CcSEcCtD
Nimodipine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000572	0.0227	CcSEcCtD
Nimodipine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000557	0.0221	CcSEcCtD
Nimodipine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000547	0.0217	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000482	0.0191	CcSEcCtD
Nimodipine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000466	0.0185	CcSEcCtD
Nimodipine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000451	0.0179	CcSEcCtD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.00045	0.00414	CbGpPWpGaD
Nimodipine—CACNB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00045	0.00414	CbGpPWpGaD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.000449	0.00414	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—SCN5A—dilated cardiomyopathy	0.000448	0.00413	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.000441	0.00406	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.000435	0.00401	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.000433	0.00398	CbGpPWpGaD
Nimodipine—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.000432	0.00398	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—FAS—dilated cardiomyopathy	0.000425	0.00392	CbGpPWpGaD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.000423	0.0039	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000422	0.00389	CbGpPWpGaD
Nimodipine—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00042	0.00387	CbGpPWpGaD
Nimodipine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000418	0.0166	CcSEcCtD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.000417	0.00384	CbGpPWpGaD
Nimodipine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000412	0.0163	CcSEcCtD
Nimodipine—CACNB4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000407	0.00375	CbGpPWpGaD
Nimodipine—CACNB4—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.000406	0.00374	CbGpPWpGaD
Nimodipine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000395	0.0157	CcSEcCtD
Nimodipine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000391	0.0155	CcSEcCtD
Nimodipine—Angiopathy—Furosemide—dilated cardiomyopathy	0.000388	0.0154	CcSEcCtD
Nimodipine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000387	0.0153	CcSEcCtD
Nimodipine—CACNB4—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.000385	0.00355	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.000385	0.00355	CbGpPWpGaD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.000383	0.00352	CbGpPWpGaD
Nimodipine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000382	0.0152	CcSEcCtD
Nimodipine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00037	0.0147	CcSEcCtD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.000367	0.00338	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.000365	0.00336	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—SCN5A—dilated cardiomyopathy	0.000358	0.0033	CbGpPWpGaD
Nimodipine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000358	0.0142	CcSEcCtD
Nimodipine—Depression—Lisinopril—dilated cardiomyopathy	0.000357	0.0141	CcSEcCtD
Nimodipine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000355	0.0141	CcSEcCtD
Nimodipine—Rash—Spironolactone—dilated cardiomyopathy	0.000352	0.014	CcSEcCtD
Nimodipine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000352	0.014	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.000351	0.00324	CbGpPWpGaD
Nimodipine—Headache—Spironolactone—dilated cardiomyopathy	0.00035	0.0139	CcSEcCtD
Nimodipine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000349	0.0138	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—SCN5A—dilated cardiomyopathy	0.000349	0.00321	CbGpPWpGaD
Nimodipine—Anaemia—Furosemide—dilated cardiomyopathy	0.000344	0.0137	CcSEcCtD
Nimodipine—AHR—Adipogenesis—LMNA—dilated cardiomyopathy	0.000339	0.00312	CbGpPWpGaD
Nimodipine—CACNA1S—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000339	0.00312	CbGpPWpGaD
Nimodipine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000338	0.0134	CcSEcCtD
Nimodipine—CACNB3—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000337	0.00311	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.000333	0.00307	CbGpPWpGaD
Nimodipine—Nausea—Spironolactone—dilated cardiomyopathy	0.000332	0.0132	CcSEcCtD
Nimodipine—CACNA1S—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00033	0.00303	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000328	0.00302	CbGpPWpGaD
Nimodipine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000327	0.013	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000326	0.003	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—ABCC9—dilated cardiomyopathy	0.000326	0.003	CbGpPWpGaD
Nimodipine—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.000325	0.00299	CbGpPWpGaD
Nimodipine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000321	0.0127	CcSEcCtD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.000321	0.00295	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00032	0.00295	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000317	0.00292	CbGpPWpGaD
Nimodipine—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.000316	0.00291	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—ACTN2—dilated cardiomyopathy	0.000312	0.00287	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.000309	0.00284	CbGpPWpGaD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.000308	0.00284	CbGpPWpGaD
Nimodipine—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.000308	0.00284	CbGpPWpGaD
Nimodipine—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.0003	0.00276	CbGpPWpGaD
Nimodipine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000298	0.0118	CcSEcCtD
Nimodipine—Flushing—Lisinopril—dilated cardiomyopathy	0.000298	0.0118	CcSEcCtD
Nimodipine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000298	0.0118	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000296	0.00272	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000294	0.0117	CcSEcCtD
Nimodipine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000291	0.0116	CcSEcCtD
Nimodipine—Hypotension—Furosemide—dilated cardiomyopathy	0.000284	0.0113	CcSEcCtD
Nimodipine—CACNA1D—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000275	0.00253	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.00027	0.00249	CbGpPWpGaD
Nimodipine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000269	0.0107	CcSEcCtD
Nimodipine—CACNA1D—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000268	0.00246	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.000264	0.00243	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000262	0.0104	CcSEcCtD
Nimodipine—CACNB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00026	0.0024	CbGpPWpGaD
Nimodipine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000258	0.0102	CcSEcCtD
Nimodipine—CACNB3—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000256	0.00236	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—SCN5A—dilated cardiomyopathy	0.000255	0.00235	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000253	0.00233	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00025	0.0023	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00025	0.0023	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000249	0.00229	CbGpPWpGaD
Nimodipine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000247	0.0098	CcSEcCtD
Nimodipine—CACNB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000243	0.00224	CbGpPWpGaD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000242	0.00223	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00024	0.00221	CbGpPWpGaD
Nimodipine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000238	0.00944	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.000238	0.00219	CbGpPWpGaD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000235	0.00216	CbGpPWpGaD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.000231	0.00213	CbGpPWpGaD
Nimodipine—Oedema—Lisinopril—dilated cardiomyopathy	0.000228	0.00905	CcSEcCtD
Nimodipine—CACNB3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000225	0.00207	CbGpPWpGaD
Nimodipine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000224	0.00889	CcSEcCtD
Nimodipine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000223	0.00886	CcSEcCtD
Nimodipine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000223	0.00883	CcSEcCtD
Nimodipine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000221	0.00875	CcSEcCtD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.00022	0.00202	CbGpPWpGaD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00022	0.00202	CbGpPWpGaD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.000219	0.00202	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—SCN5A—dilated cardiomyopathy	0.000219	0.00202	CbGpPWpGaD
Nimodipine—CACNB1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000219	0.00201	CbGpPWpGaD
Nimodipine—Pruritus—Furosemide—dilated cardiomyopathy	0.000215	0.00853	CcSEcCtD
Nimodipine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000213	0.00846	CcSEcCtD
Nimodipine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000208	0.00825	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000208	0.00825	CcSEcCtD
Nimodipine—CACNA1D—Axon guidance—SCN5A—dilated cardiomyopathy	0.000207	0.00191	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000206	0.0019	CbGpPWpGaD
Nimodipine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000203	0.00807	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000203	0.00187	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000203	0.00187	CbGpPWpGaD
Nimodipine—Dizziness—Furosemide—dilated cardiomyopathy	0.000201	0.00798	CcSEcCtD
Nimodipine—CACNB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000199	0.00183	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.000198	0.00183	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—FAS—dilated cardiomyopathy	0.000198	0.00182	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000197	0.00781	CcSEcCtD
Nimodipine—CACNA1D—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000195	0.0018	CbGpPWpGaD
Nimodipine—Vomiting—Furosemide—dilated cardiomyopathy	0.000193	0.00767	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000193	0.00178	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000193	0.00178	CbGpPWpGaD
Nimodipine—Rash—Furosemide—dilated cardiomyopathy	0.000192	0.00761	CcSEcCtD
Nimodipine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000192	0.0076	CcSEcCtD
Nimodipine—Headache—Furosemide—dilated cardiomyopathy	0.00019	0.00756	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—PSEN2—dilated cardiomyopathy	0.000189	0.00174	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.000188	0.00173	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.000188	0.00173	CbGpPWpGaD
Nimodipine—CACNB3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000186	0.00171	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—AGT—dilated cardiomyopathy	0.000185	0.00171	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000182	0.00168	CbGpPWpGaD
Nimodipine—CACNB3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000182	0.00168	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—SCN5A—dilated cardiomyopathy	0.000182	0.00168	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000181	0.00166	CbGpPWpGaD
Nimodipine—Nausea—Furosemide—dilated cardiomyopathy	0.000181	0.00716	CcSEcCtD
Nimodipine—CACNB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000181	0.00166	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—GJA1—dilated cardiomyopathy	0.00018	0.00166	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.000178	0.00164	CbGpPWpGaD
Nimodipine—CACNB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000177	0.00163	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000176	0.00162	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000172	0.00159	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000172	0.00158	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000171	0.00157	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—FAS—dilated cardiomyopathy	0.000171	0.00157	CbGpPWpGaD
Nimodipine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000168	0.00667	CcSEcCtD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.000165	0.00152	CbGpPWpGaD
Nimodipine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000161	0.0064	CcSEcCtD
Nimodipine—CACNA1S—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00016	0.00148	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000159	0.00146	CbGpPWpGaD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.000157	0.00144	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000156	0.00144	CbGpPWpGaD
Nimodipine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000156	0.00619	CcSEcCtD
Nimodipine—CACNB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000152	0.0014	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—PSEN2—dilated cardiomyopathy	0.000151	0.00139	CbGpPWpGaD
Nimodipine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000151	0.00598	CcSEcCtD
Nimodipine—CACNA1D—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000148	0.00136	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—PSEN2—dilated cardiomyopathy	0.000147	0.00135	CbGpPWpGaD
Nimodipine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000145	0.00575	CcSEcCtD
Nimodipine—Rash—Lisinopril—dilated cardiomyopathy	0.000144	0.00571	CcSEcCtD
Nimodipine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000144	0.0057	CcSEcCtD
Nimodipine—Headache—Lisinopril—dilated cardiomyopathy	0.000143	0.00567	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00014	0.00129	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—FAS—dilated cardiomyopathy	0.000139	0.00128	CbGpPWpGaD
Nimodipine—Nausea—Lisinopril—dilated cardiomyopathy	0.000136	0.00538	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000135	0.00124	CbGpPWpGaD
Nimodipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000132	0.00122	CbGpPWpGaD
Nimodipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00013	0.0012	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00013	0.0012	CbGpPWpGaD
Nimodipine—CACNA1S—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00013	0.0012	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000125	0.00115	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—FAS—dilated cardiomyopathy	0.000122	0.00112	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—ITGB1—dilated cardiomyopathy	0.000118	0.00109	CbGpPWpGaD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000114	0.00105	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000108	0.000993	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—PSEN2—dilated cardiomyopathy	0.000108	0.000991	CbGpPWpGaD
Nimodipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000107	0.000989	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000107	0.000988	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000106	0.000978	CbGpPWpGaD
Nimodipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000105	0.00097	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000105	0.000966	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000102	0.000937	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000102	0.000936	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TAZ—dilated cardiomyopathy	9.56e-05	0.000881	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—RAC1—dilated cardiomyopathy	9.5e-05	0.000875	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—ITGB1—dilated cardiomyopathy	9.45e-05	0.00087	CbGpPWpGaD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.43e-05	0.000869	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	9.27e-05	0.000854	CbGpPWpGaD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	9.26e-05	0.000853	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—PSEN2—dilated cardiomyopathy	9.23e-05	0.00085	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—ITGB1—dilated cardiomyopathy	9.19e-05	0.000847	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	8.93e-05	0.000822	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—PSEN2—dilated cardiomyopathy	8.74e-05	0.000805	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—SDHA—dilated cardiomyopathy	8.65e-05	0.000796	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—ITGB1—dilated cardiomyopathy	8.44e-05	0.000777	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—TNF—dilated cardiomyopathy	8.41e-05	0.000774	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	7.83e-05	0.000721	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PSEN2—dilated cardiomyopathy	7.68e-05	0.000707	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—PSEN2—dilated cardiomyopathy	7.68e-05	0.000707	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—RAC1—dilated cardiomyopathy	7.6e-05	0.0007	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.41e-05	0.000682	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—RAC1—dilated cardiomyopathy	7.39e-05	0.000681	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TNF—dilated cardiomyopathy	7.25e-05	0.000668	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.21e-05	0.000664	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—CD36—dilated cardiomyopathy	7.2e-05	0.000663	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—RAF1—dilated cardiomyopathy	7.1e-05	0.000654	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—RAC1—dilated cardiomyopathy	6.78e-05	0.000624	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—ITGB1—dilated cardiomyopathy	6.74e-05	0.000621	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—ITGB1—dilated cardiomyopathy	6.73e-05	0.00062	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PSEN2—dilated cardiomyopathy	6.59e-05	0.000606	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ITGB1—dilated cardiomyopathy	6.56e-05	0.000604	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—RAF1—dilated cardiomyopathy	6.3e-05	0.00058	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PSEN2—dilated cardiomyopathy	6.24e-05	0.000574	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ANKRD1—dilated cardiomyopathy	6.21e-05	0.000572	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TNF—dilated cardiomyopathy	5.89e-05	0.000542	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ANKRD1—dilated cardiomyopathy	5.88e-05	0.000542	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TAZ—dilated cardiomyopathy	5.84e-05	0.000538	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ITGB1—dilated cardiomyopathy	5.77e-05	0.000532	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CD36—dilated cardiomyopathy	5.75e-05	0.00053	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—RAF1—dilated cardiomyopathy	5.68e-05	0.000523	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CD36—dilated cardiomyopathy	5.6e-05	0.000515	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TAZ—dilated cardiomyopathy	5.53e-05	0.000509	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—RAF1—dilated cardiomyopathy	5.52e-05	0.000509	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PSEN2—dilated cardiomyopathy	5.48e-05	0.000505	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ITGB1—dilated cardiomyopathy	5.47e-05	0.000503	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—RAC1—dilated cardiomyopathy	5.42e-05	0.000499	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—RAC1—dilated cardiomyopathy	5.41e-05	0.000498	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SDHA—dilated cardiomyopathy	5.28e-05	0.000487	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—RAC1—dilated cardiomyopathy	5.27e-05	0.000486	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TNF—dilated cardiomyopathy	5.17e-05	0.000476	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ANKRD1—dilated cardiomyopathy	5.17e-05	0.000476	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NPPA—dilated cardiomyopathy	5.11e-05	0.000471	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—RAF1—dilated cardiomyopathy	5.04e-05	0.000464	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SDHA—dilated cardiomyopathy	5e-05	0.000461	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—RAF1—dilated cardiomyopathy	4.9e-05	0.000451	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TAZ—dilated cardiomyopathy	4.86e-05	0.000448	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ITGB1—dilated cardiomyopathy	4.81e-05	0.000443	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ITGB1—dilated cardiomyopathy	4.8e-05	0.000442	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—RAC1—dilated cardiomyopathy	4.64e-05	0.000427	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	4.53e-05	0.000417	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—RAF1—dilated cardiomyopathy	4.5e-05	0.000414	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SDHA—dilated cardiomyopathy	4.4e-05	0.000405	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—RAC1—dilated cardiomyopathy	4.39e-05	0.000405	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—EGFR—dilated cardiomyopathy	4.32e-05	0.000398	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ITGB1—dilated cardiomyopathy	4.12e-05	0.000379	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CD36—dilated cardiomyopathy	4.1e-05	0.000377	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ITGB1—dilated cardiomyopathy	3.9e-05	0.000359	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—RAC1—dilated cardiomyopathy	3.86e-05	0.000356	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—RAC1—dilated cardiomyopathy	3.86e-05	0.000356	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—RAF1—dilated cardiomyopathy	3.59e-05	0.000331	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—RAF1—dilated cardiomyopathy	3.59e-05	0.000331	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CD36—dilated cardiomyopathy	3.51e-05	0.000324	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—RAF1—dilated cardiomyopathy	3.5e-05	0.000322	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—RAF1—dilated cardiomyopathy	3.47e-05	0.000319	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—dilated cardiomyopathy	3.45e-05	0.000318	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ITGB1—dilated cardiomyopathy	3.43e-05	0.000316	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—dilated cardiomyopathy	3.36e-05	0.000309	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CD36—dilated cardiomyopathy	3.33e-05	0.000306	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RAC1—dilated cardiomyopathy	3.31e-05	0.000305	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RAC1—dilated cardiomyopathy	3.14e-05	0.000289	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—dilated cardiomyopathy	3.08e-05	0.000284	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—RAF1—dilated cardiomyopathy	3.08e-05	0.000283	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—dilated cardiomyopathy	2.94e-05	0.00027	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CD36—dilated cardiomyopathy	2.92e-05	0.000269	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—RAF1—dilated cardiomyopathy	2.91e-05	0.000268	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RAC1—dilated cardiomyopathy	2.76e-05	0.000254	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—RAF1—dilated cardiomyopathy	2.56e-05	0.000236	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—RAF1—dilated cardiomyopathy	2.56e-05	0.000236	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—dilated cardiomyopathy	2.47e-05	0.000227	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—dilated cardiomyopathy	2.46e-05	0.000227	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—dilated cardiomyopathy	2.4e-05	0.000221	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GPX1—dilated cardiomyopathy	2.35e-05	0.000216	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—dilated cardiomyopathy	2.35e-05	0.000216	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	2.29e-05	0.000211	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CD36—dilated cardiomyopathy	2.29e-05	0.000211	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—dilated cardiomyopathy	2.28e-05	0.00021	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RAF1—dilated cardiomyopathy	2.2e-05	0.000202	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	2.15e-05	0.000198	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—dilated cardiomyopathy	2.11e-05	0.000194	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RAF1—dilated cardiomyopathy	2.08e-05	0.000191	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AGT—dilated cardiomyopathy	2.06e-05	0.00019	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—dilated cardiomyopathy	2e-05	0.000184	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	1.95e-05	0.000179	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RAF1—dilated cardiomyopathy	1.83e-05	0.000168	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—dilated cardiomyopathy	1.76e-05	0.000162	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—dilated cardiomyopathy	1.76e-05	0.000162	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—dilated cardiomyopathy	1.67e-05	0.000154	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—dilated cardiomyopathy	1.51e-05	0.000139	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPX1—dilated cardiomyopathy	1.44e-05	0.000132	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—dilated cardiomyopathy	1.43e-05	0.000132	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—dilated cardiomyopathy	1.43e-05	0.000131	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CD36—dilated cardiomyopathy	1.4e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPX1—dilated cardiomyopathy	1.36e-05	0.000125	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—dilated cardiomyopathy	1.36e-05	0.000125	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CD36—dilated cardiomyopathy	1.32e-05	0.000122	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AGT—dilated cardiomyopathy	1.26e-05	0.000116	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—dilated cardiomyopathy	1.25e-05	0.000115	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPX1—dilated cardiomyopathy	1.19e-05	0.00011	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—dilated cardiomyopathy	1.19e-05	0.00011	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AGT—dilated cardiomyopathy	1.19e-05	0.00011	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CD36—dilated cardiomyopathy	1.16e-05	0.000107	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.06e-05	9.8e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AGT—dilated cardiomyopathy	1.05e-05	9.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1e-05	9.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.05e-06	8.33e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.29e-06	4.87e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	5.15e-06	4.74e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.64e-06	4.27e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.46e-06	2.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.39e-06	2.2e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.16e-06	1.98e-05	CbGpPWpGaD
